• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

Rain Oncology Looks Like a Rainmaker

Buyers of RAIN are still more aggressive than sellers.
By BRUCE KAMICH
Feb 13, 2023 | 11:29 AM EST
Stocks quotes in this article: RAIN

I reviewed the charts of Rain Oncology (RAIN) on January 5 and recommended that "RAIN shares may continue to trade sideways for a bit longer but further strength is likely in the weeks ahead. Traders could go long RAIN on strength above $9, looking for gains to the $17 area. Risk to $6."

Let's check the charts again.

In this daily bar chart of RAIN, below, I can see that the price of RAIN surged higher in early January and then moved sideways around the past four weeks. RAIN is trading above the rising 50-day moving average line and above the rising 200-day line.

The On-Balance-Volume (OBV) line continues to rise telling me that buyers of RAIN are still more aggressive than sellers. The Moving Average Convergence Divergence (MACD) oscillator has been weakening but remains above the zero line. 

 
In this weekly Japanese candlestick chart of RAIN, below, I see a number of recent spinning tops (small real bodies). A large upper shadow in early January tells me that traders rejected that rally but they may not be looking to sell the next rally. We'll see.
 
Prices trade above the rising 40-week moving average line. The weekly OBV line is very strong and confirms the price gains. The MACD oscillator is bullish.
 
 
In this daily Point and Figure chart of RAIN, below, I can see an upside price target in the $16 area.
 
 
In this weekly Point and Figure chart of RAIN, below, I can see an upside price target in the $30 area.
 
 
Bottom line strategy: Traders who may have gone long RAIN should continue to hold those longs or consider going long at current levels. Risk to $8. $16 and then $30 are our price targets.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Stocks | Investing | Technical Analysis | Trading | Biotechnology | Healthcare

More from Investing

Market's Narrow and Dull but Not Bad

James "Rev Shark" DePorre
Mar 29, 2023 4:26 PM EDT

Here are the two things that stood out in Wednesday's trading.

Battery Maker Enovix Could Soon Be Charged Up to Rally Further

Bruce Kamich
Mar 29, 2023 2:56 PM EDT

The stock has been impressive but gains from here may be harder to achieve.

This Software ETF Could Tell Us Where the Industry Is Headed

Bruce Kamich
Mar 29, 2023 1:54 PM EDT

Let's see the charts of the iShares Expanded Tech-Software Sector exchange-traded fund.

Add This 'Best Idea' to Your Precious Metals Portfolio

Bruce Kamich
Mar 29, 2023 1:21 PM EDT

Shares of this Canada-based company could rise more than 30% from here.

Except for Energy, I'd Be Wary of Cyclical Stocks

Bret Jensen
Mar 29, 2023 11:30 AM EDT

Another increasing concern for equities is that we are likely to see an 'earnings recession'.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:00 PM EDT CHRIS VERSACE

    AAP Podcast: This Solar Company Is a Head-Turner

    Listen to my interview with Brian Roth, CEO of sol...
  • 01:56 PM EDT PETER TCHIR

    Very Cautious

    I am very cautious here. I don't like how the c...
  • 08:58 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How to Adjust Your Trading Style as Market Conditi...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login